Overview
Naohiro Miyashita practices practicing medicine in Sapporo, Japan.
Their clinical expertise encompasses Essential Thrombocythemia and Wilms Tumor.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Naohiro Miyashita
Is Naohiro Miyashita a top-rated expert for Essential Thrombocythemia?
MediFind is an objective health platform that identifies experts based on real-world data. Naohiro Miyashita is classified as an Experienced expert for Essential Thrombocythemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Naohiro Miyashita participate in research or clinical trials?
Yes. Naohiro Miyashita has published 10 articles and abstracts on conditions like Essential Thrombocythemia. You can view a list of Naohiro Miyashita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Essential ThrombocythemiaMiyashita isExperienced. Learn about Essential Thrombocythemia.
- Wilms TumorMiyashita isExperienced. Learn about Wilms Tumor.